Drugs / Autologous cytokines
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02350972 | Jul 1978 → May 2002 | metastatic melanoma | NYU Langone Health | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous cytokines | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02350972 ↗ |
| Modality | Protein / enzyme biologic | “Autologous cytokines obtained from patients' blood mononuclear cells” NCT02350972 ↗ |
| Route | Other | “injected weekly into multiple metastatic nodules” NCT02350972 ↗ |